Class information for:
Level 1: CRIZOTINIB//ALK//ANAPLASTIC LYMPHOMA KINASE

Basic class information
Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY 2934640
196 3       LUNG CANCER//NON SMALL CELL LUNG CANCER//THORAC SURG 53631
2113 2             CRIZOTINIB//ALK//ANAPLASTIC LYMPHOMA KINASE 5482
4265 1                   CRIZOTINIB//ALK//ANAPLASTIC LYMPHOMA KINASE 1850

Terms with highest relevance score


rank Category termType chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 CRIZOTINIB authKW 3405648 15% 72% 276
2 ALK authKW 2074830 15% 45% 269
3 ANAPLASTIC LYMPHOMA KINASE authKW 1777170 10% 54% 193
4 ROS1 authKW 1101181 4% 81% 80
5 ALECTINIB authKW 1078989 4% 93% 68
6 EML4 ALK authKW 1002941 4% 71% 83
7 CERITINIB authKW 969052 3% 89% 64
8 ALK INHIBITOR authKW 942858 3% 86% 64
9 ALK REARRANGEMENT authKW 597260 3% 75% 47
10 ANAPLASTIC LYMPHOMA KINASE ALK authKW 387531 2% 49% 46

Web of Science journal categories


chi_square_rank Category chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 Oncology 29339 65% 0% 1195
2 Respiratory System 9457 19% 0% 352
3 Pathology 1605 9% 0% 162
4 Cell Biology 558 11% 0% 199
5 Chemistry, Medicinal 408 5% 0% 95
6 Pharmacology & Pharmacy 101 7% 0% 130
7 Medical Laboratory Technology 89 1% 0% 26
8 Genetics & Heredity 70 4% 0% 75
9 Medicine, Research & Experimental 52 3% 0% 60
10 Biochemistry & Molecular Biology 23 8% 0% 149

Address terms


chi_square_rank term chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 PATHOL PROJECT MOL TARGETS 83839 1% 31% 16
2 LOWE THORAC ONCOL 66361 1% 14% 27
3 P DISTHORAC DIS 47313 0% 56% 5
4 THORAC ONCOL SERV SOLID TUMOR ONCOL 47166 0% 46% 6
5 LUNG CANC IMMUNOL 45414 0% 33% 8
6 DIANAS TER EUT 44813 1% 26% 10
7 PREDICT MOL MED 44496 0% 29% 9
8 WORLDWIDE DISCOVERY 39620 1% 21% 11
9 THORAC ONCOL 39266 4% 3% 72
10 CHAO FAMILY COMPREHENS CANC 38663 2% 6% 36

Journals


chi_square_rank term chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 JOURNAL OF THORACIC ONCOLOGY 167476 9% 6% 165
2 LUNG CANCER 56438 7% 3% 123
3 CLINICAL LUNG CANCER 16838 2% 3% 29
4 ONCOTARGET 5025 4% 0% 70
5 THORACIC CANCER 4412 1% 2% 12
6 CLINICAL CANCER RESEARCH 4195 3% 0% 62
7 CANCER DISCOVERY 3942 1% 2% 11
8 EXPERT REVIEW OF ANTICANCER THERAPY 3552 1% 1% 19
9 ONCOTARGETS AND THERAPY 3046 1% 1% 20
10 THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY 2343 0% 3% 5

Author Key Words


chi_square_rank term chi_square shrOfCwithTerm shrOfTermInClass termInClass LCSH search Wikipedia search
1 CRIZOTINIB 3405648 15% 72% 276 Search CRIZOTINIB Search CRIZOTINIB
2 ALK 2074830 15% 45% 269 Search ALK Search ALK
3 ANAPLASTIC LYMPHOMA KINASE 1777170 10% 54% 193 Search ANAPLASTIC+LYMPHOMA+KINASE Search ANAPLASTIC+LYMPHOMA+KINASE
4 ROS1 1101181 4% 81% 80 Search ROS1 Search ROS1
5 ALECTINIB 1078989 4% 93% 68 Search ALECTINIB Search ALECTINIB
6 EML4 ALK 1002941 4% 71% 83 Search EML4+ALK Search EML4+ALK
7 CERITINIB 969052 3% 89% 64 Search CERITINIB Search CERITINIB
8 ALK INHIBITOR 942858 3% 86% 64 Search ALK+INHIBITOR Search ALK+INHIBITOR
9 ALK REARRANGEMENT 597260 3% 75% 47 Search ALK+REARRANGEMENT Search ALK+REARRANGEMENT
10 ANAPLASTIC LYMPHOMA KINASE ALK 387531 2% 49% 46 Search ANAPLASTIC+LYMPHOMA+KINASE+ALK Search ANAPLASTIC+LYMPHOMA+KINASE+ALK

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.

Classes with closest relation at Level 1


rank cluster_id2 link
1 147 GEFITINIB//EGFR MUTATION//ERLOTINIB
2 6257 ANAPLASTIC LARGE CELL LYMPHOMA//LYMPHOMATOID PAPULOSIS//CD30
3 21842 RESEARCH BIOPSY//PRECISION ONCOLOGY//PERSONALIZED CANC THER Y
4 16222 TTF 1//NAPSIN A//THYROID TRANSCRIPTION FACTOR 1
5 18663 TRANS SPLICING//SPLICED LEADER//CHIMERIC RNA
6 11325 FGFR//FGFR4//FIBROBLAST GROWTH FACTOR RECEPTOR 4
7 13044 CANCER GENOME//DRIVER GENE//PRECIS HLTH
8 13159 MIDKINE//PLEIOTROPHIN//HB GAM
9 2961 BRONCHIOLOALVEOLAR CARCINOMA//SEGMENTECTOMY//GROUND GLASS OPACITY
10 38002 SYSTEMS PATHOLOGY//ABT KLIN ONKOL RADIOTHER IE//AOVV

Go to start page